Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GMALL09 Trial for Adult Acute Lymphoblastic Leukemia
NCT00199069Phase 4Completed
- Sponsor
- Goethe University Frankfurt
- Start
- Apr 1993
- Primary completion
- Jan 1999
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of asparaginase escherichia coli, vincristine, daunorubicin, doxorubicin, cyclophosphamide in acute lymphoblastic leukemia (ALL), sponsored by Goethe University Frankfurt. Started Apr 1993; status: completed.
02
Drugs
asparaginase escherichia colivincristinedaunorubicindoxorubicincyclophosphamide
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00199069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199069.